FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Heritage Pharmaceuticals Losartan Potassium Tablets 100 mg 1000 film Recall

Losartan Potassium Tablets USP 100 mg 1000 film coated tablets Rx only Manufactured…

Heritage Pharmaceuticals, Inc. · East Brunswick, NJ

Risk level
Class II
Reported by FDA
May 29, 2019
Recall ID
D-1290-2019
Check your lot numberHow we source this data

Summary

Heritage Pharmaceuticals recalled Losartan Potassium Tablets 100 mg 1000 film starting May 3, 2019. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-1290-2019 on May 29, 2019. Reason: CGMP Deviations: FDA lab confirmed presence of an impurity, N-Methylnitrosobutyric acid (NMBA) in the finished product above the interim acceptable daily intake level at the manufacturer. Status: Terminated.

Why it was recalled

CGMP Deviations: FDA lab confirmed presence of an impurity, N-Methylnitrosobutyric acid (NMBA) in the finished product above the interim acceptable daily intake level at the manufacturer

Product description

Losartan Potassium Tablets USP 100 mg 1000 film coated tablets Rx only Manufactured by: Vivimed Life Sciences Private Limited, Plot No. 101, 102, 107 & 108 SIDCO Pharmaceutical Complex, Alathur, Kanchipuram - 603 110, Tamilnadu, India. Manufactured for: Heritage Pharmaceuticals Inc., East Brunswick, NJ 08816. 1-866-901-DRUG (3784) NDC 23155-646-10

Lot numbers, UPCs & expiration codes

CLO17014A exp 12/2019 CLO17015A exp 01/2020 CLO17016A exp 01/2020 CLO17017A exp 01/2020 CLO18001A exp 01/2020 CLO18002B exp 01/2020

Where it was sold

Nationwide

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-1290-2019
Classification
Class II
Status
Terminated
Recall initiated
May 3, 2019
FDA report date
May 29, 2019
Quantity
3697 bottles
Recall type
Voluntary: Firm initiated
Recalling firm
Heritage Pharmaceuticals, Inc.

Original FDA data

Every field from FDA enforcement report D-1290-2019, exactly as published.

Show all FDA fields
City
East Brunswick
State
NJ
Status
Terminated
Country
United States
Event ID
82782
Address
1 Tower Center Blvd Ste 1700
Code information
CLO17014A exp 12/2019 CLO17015A exp 01/2020 CLO17016A exp 01/2020 CLO17017A exp 01/2020 CLO18001A exp 01/2020 CLO18002B exp 01/2020
Postal code
08816-1145
Report date
May 29, 2019
Product type
Drugs
Recall number
D-1290-2019
Classification
Class II
Recalling firm
Heritage Pharmaceuticals, Inc.
Product quantity
3697 bottles
Termination date
Nov 16, 2020
Reason for recall
CGMP Deviations: FDA lab confirmed presence of an impurity, N-Methylnitrosobutyric acid (NMBA) in the finished product above the interim acceptable daily intake level at the manufacturer
Voluntary / mandated
Voluntary: Firm initiated
Product description
Losartan Potassium Tablets USP 100 mg 1000 film coated tablets Rx only Manufactured by: Vivimed Life Sciences Private Limited, Plot No. 101, 102, 107 & 108 SIDCO Pharmaceutical Complex, Alathur, Kanchipuram - 603 110, Tamilnadu, India. Manufactured for: Heritage Pharmaceuticals Inc., East Brunswick, NJ 08816. 1-866-901-DRUG (3784) NDC 23155-646-10
Distribution pattern
Nationwide
Recall initiation date
May 3, 2019
Initial firm notification
Press Release
Center classification date
May 21, 2019

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-1290-2019, published May 29, 2019. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls